The TOPIX 250 index rose for 3 consecutive days on the Tokyo Stock Exchange's growth market, with mixed performances among main stocks and lack of direction in the market sentiment.
Tokyo Stock Exchange Growth Market Index 875.06 +6.42 / Volume 0.2 billion 0.88 million shares / Transaction value of 137.4 billion yen. Tokyo Stock Exchange Growth Market 250 Index 681.33 +4.20 / Volume 0.1 billion 45.42 million shares / Transaction value of 109.8 billion yen. Today's Growth Market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, have risen for three consecutive days. There are 345 rising stocks, 214 falling stocks, and 27 unchanged stocks. The U.S. stock market rose on the 15th. Dow Inc. increased by 210.82 dollars (+0.
Stocks that hit the daily limit up or down in the morning session.
• Stop-high <194A> WOLVES HAND <2484> Demae-kan <3750> Saito-ri Cell Research Institute <3791> IG Port <3913> GreenBee <4198> Tenda <4288> Aztent <4582> SimBio Pharmaceutical <4586> Medirex <4935> Libertad <5026> Triple Eyes <5250> Prime Strategy <5704> JMC <6182> Material <6224> JRC <7776> Cell Seed • S
Volume change rate ranking (9am) - Matsuya, Demae-can, etc. ranked in.
In the volume change rate ranking, you can understand the interest of market participants, such as trends in market search, by comparing the average volume of the last 5 days and the volume on the day of delivery. Top volume change rate [as of 9:32 am on July 16] (comparison of average volume for the last 5 days) stock code stock name volume 5-day average volume volume change rate stock price change rate <9252> Last One Mile 60,000 107,185.08 135.97% 0.0389
Emerging Market Outlook: Will funds flow towards major processing, bio, and earnings stocks as the Growth Market 250 Index enters a battle to break through the 200-day moving average?
Emerging markets saw an inflow of funds due to the sharp decline in large cap stocks over the weekend, causing an increase in emerging markets this week. During the same period, the growth market index rose significantly by +2.60%, and the growth market 250 index rose by +2.99%, compared to the Nikkei average of +0.68%. Although trading volume in emerging markets declined at the beginning of the week, a stagnant market with little price fluctuations occurred in both the growth market index and the growth market 250 index. However, at the end of the week, large cap stocks plummeted more than 1000 yen due to the decline of the Nikkei average, while emerging markets saw
The TOPIX Gross Index rose significantly, with growth core 20 stocks all expanding gains.
Tokyo Stock Exchange Growth Market Index is at 868.64, up 24.20 points, with a volume of 0.2 billion 33.78 million shares and a trading value of 185.1 billion yen. The TSE Growth Market 250 Index is at 677.13, up 21.27 points, with a volume of 0.1 billion 77.28 million shares and a trading value of 159.2 billion yen. Today's growth market has seen both the TSE Growth Market Index and TSE Growth Market 250 Index continue to rise significantly. The number of rising stocks is 291, the number of falling stocks is 245, and unchanged is 45. The US stock market on the 11th was mixed. The Dow average was up 32.39 dollars.
Stocks hitting the upper or lower price limit in the afternoon session.
■Stocks that hit the upper limit<194A>WOLVES HAND <4196>NEO MARKETING <4288>AZJENT <4443>Sansan <4582>Shin-Biyo Seiyaku <5250>Main Board Strategy <6532>Baycurrent Consulting■Stocks that hit the lower limit<4586>Medirex※includes temporary upper and lower limits (indicative value)
Emerging Market Stocks Digest: Creamer plummets, Boardlua surges.
<4586> Medorec 97 -50 stop loss. It has been disliked by the market due to downward revision of performance estimates. For the FY 2024 performance estimate, revenue has been revised downward from ¥0.42 billion to ¥0.44 billion (a decrease of 44.8%), and operating loss has been revised downward from a deficit of ¥1.183 billion to a deficit of ¥1.298 billion, assuming approval and milestone revenue, product revenue and cost of goods manufactured for MRX-5LBT are recognized in FY 2024.
Medrexx - Stop selling at low prices, downward revision of financial estimates for this fiscal year.
There is a stop in the downward trend of the sale price. The financial estimates have been revised downwards and are being disliked. For the performance outlook for the year ending December 2024, the revenue has been revised downward from 0.4 billion 42 million yen to 0.2 billion 44 million yen (a decrease of 44.8% in sales growth), and the operating loss has been revised downward from a deficit of 1.1 billion 83 million yen to a deficit of 1.2 billion 98 million yen. The completion report notification from the MRX-5LBT review reception has removed the prospect of recognizing milestone revenue, product sales revenue, and cost of goods manufactured in December 2024.
Medrx: Announcement of revised financial estimates.
Medrx Sees Wider FY Net Loss at Y1.26B
GROUP New Forecast Prior For Year To Dec 2024 Forecast Revenue Y244.00 mln Y442.00 mln Operating Profit (Y1.30 bln)
The TOPIX Large Cap Index rebounded for the first time in three days, with large-cap stocks dominating and continuing to consolidate at the 75-day moving average.
Tokyo Stock Exchange Growth Market index 844.44 +1.26 / volume 0.1 billion 88.63 million shares / trading value 133.1 billion yen. Tokyo Stock Exchange Growth Market 250 index 655.86 +1.35 / volume 0.1 billion 27.73 million shares / trading value 110.9 billion yen. Today's growth market rebounded for the first time in 3 days, with the Tokyo Stock Exchange Growth Market index and the Tokyo Stock Exchange Growth Market 250 index both rising. There were 291 gainers, 245 losers, and 45 unchanged. The US stock market rose on the 10th. The Dow Jones Industrial Average was up 429.39 dollars.
Medirex, HYUGA PRIMARY CARE, etc.
<205A> Logos Holdings Co., Ltd., Yuoichi Ikeda's shareholding ratio - % → 9.05%. Reporting obligation date: June 28, 2024. <205A> Logos Holdings Co., Ltd., Endeavor United Corporation's shareholding ratio - % → 53.86%. Reporting obligation date: June 28, 2024. <206A> Prism BioLab Co., Ltd., Yoshiichiro Nakashima's shareholding ratio - % → 5.29%. Reporting obligation.
Part 2 of the stocks that moved the day before, R Planner, Kasumigaseki Capital, Kawasaki Heavy Industries, etc.
Stock Name <Code> 4 day closing price ⇒ Previous day comparison. Kasumigaseki Capital <3498> 14860 -1350 Back selling is dominant after a sharp rise on the previous day. Kawasaki Heavy Industries <7012> 5978 -473 It is rumored that they are suspected of providing gold commodities to SDF members. ABC-Mart <2670> 2729.5 -145.5 There is a pre-sellout feeling without a surprise in the Q1 financial results. Ascle <2678> 2060 -100 Negative view of the slowdown in this year's earnings growth rate. ANYCOLOR <5>
The TOPIX Global Market 250 Index is slightly up, with attention turning to the main board as the increase narrows.
The Tokyo Stock Exchange Growth Market Index was 842.86, up 0.35%, with a volume of 178.08 million shares and sales of 124.5 billion yen. The Tokyo Stock Exchange Growth Market 250 Index was 653.92, up 0.89%, with a volume of 122.33 million shares and sales of 91.7 billion yen. Today's growth market saw slight gains in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. The number of rising stocks was 226, the number of falling stocks was 308, and the unchanged stocks were 50. The US stock market on the 3rd was mixed. The Dow average fell $23.85 (-)
Active and newly listed stocks during the morning session.
*World <3612> is evaluating the good Q1 financial results and the strong June monthly sales, with the stock rising by 209. *Sumitomo Pharmaceuticals <4506> seems to be reporting some president interview and other news, with the stock rising by 27. *Sumitomo Metal Mining <5713> is considering the rise in non-ferrous metal prices, such as gold prices, as material for the stock rise by 326. *Kokusai Electric <6525> is also considered as material for the stock rise by 270 due to some special feature articles. *Japan Micronics <6871> is up by 7060.
Volume change rate ranking (9:00) ~ Delta-P, Recovery and others ranked in.
*In volume change rate ranking, by comparing the volume of the last 5 days and the volume on the day of distribution, you can understand the interest of market participants, such as market trends. *Volume Change Rate Top [As of July 4th 9:32 am] (Comparison of average volume of last 5 days) Stock Code Stock Name Volume 5-day average volume Volume change rate Price change rate<2247>iF500H none 16385 107185.08 182.7% 0.0035%<
Social Wire, Medrex, etc
<1431> Lib Work Seguchi Co., Ltd. shareholding ratio 46.39% → 44.74%, report obligation date: June 28, 2024 <3929> Social Wire Co., Ltd. and Genie Co., Ltd. shareholding ratio 20.97% → 58.86%, report obligation date: July 1, 2024 <4019> Stamen Kato Atsushi Co., Ltd. shareholding ratio 36.75% → 36.75%, report obligation date 2024.
Ribomikku, F-Force G and others.
<4258> Canon Marketing Japan Inc <8060> signs a business partnership with DWTI <4576>, 700,000 shares of subscription rights with adjusted exercise prices will be delivered from October 1st. <4586> Medrek <4591> completes patient enrollment in Phase II clinical trial of umedaptanib pegol for the treatment of cartilage agenesis, and the delivery of 2 million shares of subscription rights with adjusted exercise prices will begin on the day of large-scale exercise in the 29th round.
Volume change rate ranking (10:00) - Eyes, KAKKO and others are ranked.
In the volume change rate ranking, comparing the average volume of the past 5 days with the volume on the day of delivery can help understand market participants' interests such as trends in selection. High volume change rate [as of June 27, 10:32] (comparison of average volume for the past 5 days) Code Name Volume 5-day average volume Volume change rate Stock price change rate <5242> Eyes 226,800 14,360 301.55% 0.2024%
Regill, Linkers, and other emerging market companies are subject to the 5% rule.
<176A> Legeal Corporation and Light Communications Co., Ltd. shareholding ratio increased from 5.10% to 6.86% as of the reporting obligation on June 3, 2024. <4393> Bank of Innovation Co., Ltd., owned by Daisuke Tanaka, shareholding ratio decreased from 7.77% to 6.99% as of the reporting obligation on June 4, 2024. <4564> Oncotherapy Science Co., Ltd., Long Corridor Asset Management Limited also holds its shares.
No Data